ROBIN SHERRINGTON (EVP, Strategy & Innovation) exercised options at XENON PHARMACEUTICALS INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 6/2/2020ACC: 0001209191-20-033669
Officer· EVP, Strategy & Innovation
Since Sep 2019
-1.63K
Net shares
Net seller
$22.3K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
8.23K acquired · 9.86K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+8.23K
Price / share
$3.56
Trade value
$29.30K
% of position
80.7%
6/1/2020
10.20K→18.43K
Common Shares
Direct
Shares
−1.63K
Price / share
$13.70
Trade value
$22.33K
% of position
8.8%
6/1/2020
18.43K→16.80K
Total
Net shares
+6.60K
Net value
$6.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 6/1/2020 | M · Option Exercise | +8.23K | $3.56 | $29.30K | 80.7% | 10.20K | 18.43K |
| Common Shares Direct | 6/1/2020 | F · Tax Withholding | −1.63K | $13.70 | $22.33K | 8.8% | 18.43K | 16.80K |
| Total | +6.60K | $6.97K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Shares
8.23K shares
Shares
−8.23K
Strike price
3.56
Held after
0.00
Exercisable
—
6/1/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares8.23K shares | 6/1/2020 | M · Option Exercise | −8.23K | 3.56 | — | 0.00 |